The convergence of automation, digitalization and artificial intelligence (AI) is profoundly reshaping research and quality control (QC) processes, transforming traditional laboratories into intelligent automated environments. Bruker is at the forefront of this revolutionary transition, enabling laboratories to operate as intelligent self-driving entities that significantly elevate productivity, accuracy, and sustainability.

ELITech MDx uniquely addresses critical diagnostic needs through advanced, fully automated sample-to-result (S2R) PCR platforms. Since pioneering the industry’s first fully integrated system in 2016, ELITech MDx has continually strengthened its technological leadership.

By providing a portfolio of instruments designed expressly to address specific spatial needs, Bruker enable customers to interrogate their unique spatial questions analyzing DNA, RNA, and protein across a spectrum of resolution, plex, and throughput.